FDA Clears New 1.5T MRI Coil
InkSpace Imaging’s 24-channel MRI coil, which will be included in Magnetom 1.5T scanners from Siemens Healthineers, reportedly facilitates quicker set-ups for technologists and enhanced spatial resolution.
The Food and Drug Administration (FDA) has granted 510(k) clearance for a 1.5T, 24-channel magnetic resonance imaging (MRI) coil, which reportedly enables improvements in workflow efficiency, image quality and patient comfort.
InkSpace Imaging, the developer of the new MRI coil, said high-density coil elements enhance spatial resolution and parallel imaging compatibility helps reduce artifacts while facilitating scan time reductions.
In addition to streamlining scan set-ups for technologists, the newly FDA-cleared 1.5T, 24-channel MRI coil bolsters spatial resolution and helps reduce artifacts, according to InkSpace Imaging, the developer of the new MRI coil. (Photo courtesy of InkSpace Imaging.)
The 1.5T MRI coil, which will be included in Magnetom MRI scanners from Siemens Healthineers, also streamlines scan set-ups for technologists, according to InkSpace Imaging. The company added that the ultra-lightweight coil conforms to patient anatomy, ensuring comfort for diverse body types.
“The 1.5T MR coil sets a new benchmark for image quality and operational efficiency, empowering radiologists to achieve better patient outcomes,” added Peter Fischer, the CEO of InkSpace Imaging.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).
